Relationship between Thyroid Stimulating Hormone Level and Aggressive Pathological Features of Papillary Thyroid Cancer

Abstract

T hyroid cancer has an increasing incidence due to the increase in diagnostic imaging modalities. Papillary thyroid carcinoma (PTC) is the most common differentiated thyroid cancer (DTC). [1] However, the etiology has not been clarified much, except for reasons such as age, a history of radiation to the neck region, and a previous history of PTC, which predispose to DTC. [2] Thyroid-stimulating hormone (TSH) is the main regulator and growth factor of the thyroid. Since it is the major hormone stimulating thyrocytes, increased serum concentrations of TSH have been found to be associated with cancer risk in thyroid nodules. [3,4] The basis of this view is that TSH has an effect on the proliferation of malignantly transformed DTC cells, as well as on thyrocytes. TSH has been Objectives: Thyroid-stimulating hormones (TSHs) are associated with the risk of differentiated thyroid cancer. The relationship between pre-operative TSH levels and aggressive features is unclear. We aimed to evaluate the relationship between pathological features of papillary thyroid carcinoma (PTC) and high TSH levels. Methods: Patients who were operated between 2012 and 2017 and who were found to have PTC in their pathology were included in the study. The relationship between TSH and the features of tumor aggressiveness was evaluated in the patients. Results: Of the 132 patients, TSH level was significantly higher in those with lymphovascular invasion than those without (p=0.048), in those with central metastases than in those without (p=0.014), and in those with extrathyroidal spread than in those without (p=0.003). When patients were categorized into four 25% quartiles according to TSH (mUI/mL) level; the rate of extrathyroidal invasion increased as the TSH level increased, and the level was significantly higher in quartile 1 than the others, with significant difference (p=0.030). Conclusion: Pre-operative increase in TSH level is associated with an increased risk of extrathyroidal spread and central lymph node metastasis. TSH level may be a pre-operative valuable predictive factor for patients' risk of central metastasis.

The relationship between papillary thyroid carcinoma and preoperative TSH level: A cross-sectional study from Syria

“…[ 1 , 2 ] Data from 2 studies by Haymart et al [ 8 , 20 ] demonstrated that gender significantly affects TSH levels between benign and malignant lesions. Although, other studies by Demircioglu et al [ 22 ] and Golbert et al [ 4 ] did not show a gender effect on TSH levels.…”

“…[ 9 ] Demircioglu et al and Besler et al had similar results. [ 22 , 29 ] Recently, Kim et al [ 30 ] have shown that preoperative TSH levels are a considerable predictive factor for the presence of extrathyroidal spread and lateral LNM in patients with thyroid cancer.…”

Predictive factors affecting the development of central lymph node metastasis in papillary thyroid cancer

“…[ 4 ] The most common subtype of thyroid cancers is PTC and increasing of incidence is related with PTC. [ 13 ] The prognosis of PTC, recurrence rate, follow-up of the disease, and the extent of treatment for cure of PTC has been discussed for a long time.…”

Navigating Thyroid Dysfunction and Comorbidities Among University Students in Abbottabad, Pakistan – A Cross-Sectional Evaluation of Screening Tool for Thyroid Dysfunction

“… 9 , 10 Some earlier research showed a link that a high level of thyroid-stimulating hormone (TSH) is linked with thyroid various carcinoma. 11 , 12 …”